Determination of the De Novo Minimum Selection Concentration of Trimethoprim In Vivo for Escherichia coli Using Galleria mellonella: A Pilot Study

利用大蜡螟测定甲氧苄啶对大肠杆菌体内新发最低选择浓度:一项初步研究

阅读:3

Abstract

We investigated whether the maximum residual levels of trimethoprim permitted in food (Acceptable Daily Intake-ADI) could select for de novo trimethoprim resistance in Escherichia coli in vivo. We designed chronic infection models of E. coli in Galleria mellonella and exposed them to sub-ADI doses of trimethoprim through a single-dosing regimen. The emergence of trimethoprim resistance was determined by isolating the target bacteria on selective agar plates, followed by species confirmation using MALDI-TOF mass spectrometry. The minimum inhibitory concentration (MIC) was assessed via the E-test to determine E. coli susceptibility to trimethoprim. Notably, exposure to as low as one-tenth of the ADI dose through a single-dosing regimen resulted in the selection of trimethoprim-resistant E. coli. Our findings indicate that trimethoprim doses ten-fold lower than the established ADI threshold could induce resistance to trimethoprim in E. coli. These results highlight the importance of considering antimicrobial resistance induction as a key factor when determining ADI levels in food.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。